Alex Epshinsky, CPA

Alex Epshinsky, CPA has a wealth of experience in the finance and accounting field. Alex currently holds the position of Controller at Avenue Therapeutics, where they began in January 2023. Prior to this role, Alex served as Controller at Aruvant from October 2021 to January 2023. Alex also worked as an Assistant Controller at Turnstone Biologics from September 2019 to October 2021.

Earlier in their career, Alex held various positions at Intercept Pharmaceuticals, starting as a Senior Manager, Accounting from June 2017 to January 2019, and later becoming an Associate Director, Accounting from January 2019 to September 2019. Prior to their time at Intercept Pharmaceuticals, they worked as an Accounting Supervisor at Pernix Therapeutics from October 2016 to June 2017, and as a Senior Accountant from July 2015 to September 2016.

Alex's career began at EisnerAmper LLP, where they worked as a Senior Auditor from February 2011 to June 2015. Before that, they gained experience as a Portfolio Accountant at Pzena Investment Management from January 2008 to October 2008. Alex'searliest role was as an SPA Account Administrator at Merrill Lynch from January 2006 to October 2007.

Alex Epshinsky, CPA has a Master of Science degree in Accounting from Kean University, which was obtained in the year 2010. Before that, Alex attended Rutgers University from 2001 to 2005, although the specific degree and field of study are unknown. In August 2012, Alex obtained the Certified Public Accountant (CPA) certification.